The Use of the SMART-COP Score in Predicting Severity Outcomes Among Patients With Community-Acquired Pneumonia: A Meta-Analysis.

Autor:	Memon RA; Internal Medicine, California Institute of Behavioural Neurosciences and Psychology, Fairfield, USA., Rashid MA; Medicine, Allama Iqbal Medical College, Lahore, PAK., Avva S; Medicine, Lady Hardinge Medical College, New Delhi, IND., Anirudh Chunchu V; Medicine, Avalon University School of Medicine, Willemstad, CUW., Ijaz H; Medical College, Allama Iqbal Medical College, Lahore, PAK., Ahmad Ganaie Z; Internal Medicine, Holy Family Red Crescent Medical College, Srinagar, IND., Kabir Dar A; Internal Medicine, Holy Family Red Crescent Medical College Hospital, Dhaka, BGD., Ali N; Internal Medicine, University of Health Sciences, Lahore, PAK.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 Jul 25; Vol. 14 (7), pp. e27248. Date of Electronic Publication: 2022 Jul 25 (Print Publication: 2022).
DOI:	10.7759/cureus.27248
Abstrakt:	Pneumonia is a pathological process of interstitial lung tissue and distal airway and alveolar infection and infiltration. SMART-COP (systolic blood pressure, multilobar infiltrates, albumin, respiratory rate, tachycardia, confusion, oxygen, and pH) is a severity score method designed to identify individuals who require intensive respiratory or vasopressor support (IRVS) support due to pneumonia. Therefore, it is important for management decisions in pneumonia. This meta-analysis was conducted to determine the performance of the SMART-COP score in predicting the prognosis and severity of patients presenting with community-acquired pneumonia (CAP). The current meta-analysis was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic search was conducted using Medline, Embase, and CINAHL to identify relevant studies assessing the validity of the SMART-COP score in predicting the severity of patients with CAP. Overall, nine studies were included in the current meta-analysis. A pooled sensitivity of the SMART-COP score to predict the use of IRVS is 89% (95% CI: 84%-92%) while its specificity is 68% (95% CI: 65%-70%). The pooled sensitivity of the SMART-COP score to predict 30-day mortality is 92% (95% CI: 89%-94%) while its specificity is 39% (95% CI: 37%-42%). To summarize, SMART-COP is a new, eight-variable instrument that appears to accurately identify patients with CAP who will require IRVS and 30-day mortality. Our findings show that SMART-COP will be a valuable tool for clinicians in accurately predicting illness severity in CAP patients as compared to other scoring systems. SMART-COP can be useful to identify patients who need urgent management. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Memon et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu